Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 5, 2000, Pages 451-458

  Conti, Susanna ^a   Masocco, Maria ^a   Pezzotti, Patrizio ^a   Toccaceli, Virgilia ^a   Vichi, Monica ^a   Boros, Stefano ^a   Urciuoli, Roberta ^a   Valdarchi, Catia ^a   Rezza, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS defining illness; Combined antiretroviral therapy; Survival

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN LYMPHOMA; BURKITT LYMPHOMA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034671705     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200012150-00011     Document Type: Article

References (23)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
2. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study
3. Changing patterns of mortality across Europe in patients infected with HIV-1
4. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
5. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment
6. Increasing survival time after AIDS in Italy: The role of new combination antiretroviral therapies
7. Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998
8. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
9. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
10. Prevention of opportunistic infections in the era of improved antiretroviral therapy
11. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS clinical trial group study participants
12. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals
13. Expanded European AIDS case definition
14. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
15. AIDS-associated Kaposi's sarcoma and non-Hodgkin's lymphomas reporting in Italy: A linkage study
16. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
17. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy
18. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion
19. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma
20. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
21. Malignant lymphomas associated with immunodeficiency status